OQROGet OQRO Pro
Insider trade

Idexx Laboratories (IDXX)Director sold ~$628K

Sophie V. Vandebroek, Director at Idexx Laboratories, sold ~$628K of Idexx Laboratories shares.

~$628K
Approx. value · 1,279 sh @ $491.34
1,167
Holds after · shares reported
Traded
May 9, 2025
Filed
May 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 25, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  2. Mar 13, 2025CongressDisclosed purchase of IDXX — reported range $15,001 - $50,000
  3. Mar 14, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  4. Apr 1, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  5. Apr 4, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  6. Apr 7, 2025Congress · 2 peopleMembers of Congress: 3 purchases
  7. Apr 8, 2025CongressDisclosed sale of IDXX — reported range $1,001 - $15,000
  8. Apr 9, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  9. May 9, 2025 · this disclosureInsiderDirector sold ~$628K of IDXX shares in the open market

What came next

  1. May 12, 2025CongressDisclosed sale of IDXX — reported range $100,001 - $250,000
  2. May 13, 2025InsiderDirector sold ~$1.36M of IDXX shares in the open market
  3. May 15, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  4. May 21, 2025Insider · 1 personInsiders: 2 sales (~$1.2M)
  5. Jul 9, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  6. Aug 1, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  7. Aug 6, 2025Insider · 3 peopleInsiders: 16 sales (~$28.3M)
  8. Aug 7, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  9. Aug 8, 2025InsiderOfficer sold ~$3.55M of IDXX shares in the open market
  10. Aug 11, 2025InsiderOfficer sold ~$788K of IDXX shares in the open market
  11. Aug 12, 2025Insider · 1 personInsiders: 2 sales (~$264K)
  12. Aug 22, 2025InsiderDirector sold ~$1.42M of IDXX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Idexx Laboratories

For Idexx Laboratories, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 30 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IDXX page.

Other recent filings by Sophie V. Vandebroek, Director

The full history of Sophie V. Vandebroek, Director is on the profile page.

How this filing works

Other disclosures at Idexx Laboratories

Everything OQRO holds on this company is on its IDXX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data